On March 9, 2015, Axiom’s Chairman, Dr. Stanley Feldman was appointed to the Board of Sterilis LLC as an independent Director. Sterilis is revolutionizing the regulated medical waste industry.
Dr. Feldman is the Chairman and co-founder of Axiom Valuation Solutions and has an extensive background in valuing complex capital structures of early and late stage VC and private equity financed firms, and has conducted numerous assignments to meet the requirements of FAS 123R and IRS 409A. He has led valuation teams working with Axiom clients going through the IPO process and has successfully interacted with the SEC and Big Four audit firms on valuation issues related to client S-1 filings.
Stan is a Certified Patent Valuation Analyst faculty member and leading expert in valuation issues, including Purchase Price Accounting (FAS 141R/ASC 805) and Goodwill Impairment (FAS 142/ASC 350) particularly, as they impact the valuation of intangible assets.
For more information regarding Dr. Feldman and Sterilis, please follow the link below: